MARINA KONOPLEVA to Pyrrolidines
This is a "connection" page, showing publications MARINA KONOPLEVA has written about Pyrrolidines.
Connection Strength
0.408
-
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial. Blood Adv. 2022 07 26; 6(14):4147-4156.
Score: 0.201
-
MIRROS: a randomized, placebo-controlled, Phase III trial of cytarabine ? idasanutlin in relapsed or refractory acute myeloid leukemia. Future Oncol. 2020 May; 16(13):807-815.
Score: 0.171
-
Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy. Cancer Cell. 2017 Dec 11; 32(6):748-760.e6.
Score: 0.037